Schroder Investment Management Group Bristol Myers Squibb CO Transaction History

Schroder Investment Management Group

$87.8 Billion
Q2 2024

A detailed history of Schroder Investment Management Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schroder Investment Management Group holds 6,673,552 shares of BMY stock, worth $355 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

6,673,552

Previous 4,572,299 45.96%

Holding current value

$355 Million

Previous $248 Million 11.78%

% of portfolio

0.32%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $84.6 Million - $111 Million	2,101,253 Added 45.96%	6,673,552 $277 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $53.1 Million - $60.2 Million	1,106,383 Added 31.92%	4,572,299 $248 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $33.8 Million - $40.3 Million	697,388 Added 25.19%	3,465,916 $178 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $41.5 Million - $46.4 Million	-716,893 Reduced 20.57%	2,768,528 $161 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $283 Million - $314 Million	-4,439,679 Reduced 56.02%	3,485,421 $223 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $85.9 Million - $97.5 Million	-1,307,974 Reduced 14.17%	7,925,100 $549 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $26 Million - $30.7 Million	-379,134 Reduced 3.94%	9,233,074 $664 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $43,918 - $26 Million	-337,833 Reduced 3.4%	9,612,208 $683 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $81.6 Million - $89.9 Million	1,123,694 Added 12.73%	9,950,041 $766 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $50.1 Million - $60.1 Million	814,621 Added 10.17%	8,826,347 $646 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $48.1 Million - $56.1 Million	897,369 Added 12.61%	8,011,726 $500 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $21.9 Million - $25.7 Million	370,513 Added 5.49%	7,114,357 $421 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $91.1 Million - $99.2 Million	1,470,987 Added 27.9%	6,743,844 $451 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $44.3 Million - $49.9 Million	747,373 Added 16.51%	5,272,857 $333 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $4.64 Million - $5.26 Million	-80,389 Reduced 1.75%	4,525,484 $281 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $3.62 Million - $4.01 Million	62,953 Added 1.39%	4,605,873 $270 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $3.33 Million - $3.89 Million	60,679 Added 1.35%	4,542,920 $267 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $10.1 Million - $14.7 Million	217,750 Added 5.11%	4,482,241 $259 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $33.6 Million - $43.9 Million	683,684 Added 19.09%	4,264,491 $274 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $47.4 Million - $56.3 Million	-1,109,325 Reduced 23.65%	3,580,807 $180 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $12.1 Million - $13.3 Million	270,185 Added 6.11%	4,690,132 $213 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $17.5 Million - $20.8 Million	387,057 Added 9.6%	4,419,947 $211 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $30 Million - $38.9 Million	615,786 Added 18.02%	4,032,890 $210 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $24 Million - $27.1 Million	-434,644 Reduced 11.28%	3,417,104 $212 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $157 Million - $196 Million	3,109,664 Added 419.04%	3,851,748 $213 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $5.27 Million - $6.07 Million	87,983 Added 13.45%	742,084 $46.9 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $5.71 Million - $6.22 Million	95,204 Added 17.03%	654,101 $40.1 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $30.9 Million - $35.6 Million	558,897	558,897 $35.2 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Bristol Myers Squibb CO Transaction History